Mutations of PTEN in patients with Bannayan-Riley-Ruvalcaba phenotype

Journal of Medical Genetics

Volumn 35, Issue 11, 1998, Pages 886-889

  Longy, Michel ^a   Coulon, Valérie ^a   Duboué, Bernadette ^a   David, Albert ^b   Larrègue, Marc ^c   Eng, Charis ^d   Amati, Patrizia ^c   Kraimps, Jean Louis ^c   Bottani, Armand ^f   Lacombe, Didier ^e   Bonneau, Dominique ^c  

^a INSTITUT BERGONIÉ   (France)

^b NANTES UNIVERSITY HOSPITAL   (France)

^c POITIERS UNIVERSITY HOSPITAL   (France)

^d HARVARD MEDICAL SCHOOL   (United States)

^e BORDEAUX UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Bannayan Riley Ruvalcaba syndrome; Cowden disease; PTEN

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BANNAYAN RILEY RUVALCABA SYNDROME; CANCER GENETICS; CHROMOSOME 10Q; CLINICAL ARTICLE; CONGENITAL BLOOD VESSEL MALFORMATION; COWDEN SYNDROME; ELECTROPHORESIS; FEMALE; GENE LOCUS; GENE MUTATION; GENETIC PREDISPOSITION; HUMAN; INTESTINE POLYP; LIPOMA; MACROCEPHALY; MALE; NUCLEOTIDE SEQUENCE; PENIS DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL;

EID: 17344364602     PISSN: 00222593     EISSN: None     Source Type: Journal    
DOI: 10.1136/jmg.35.11.886     Document Type: Article

References (15)

1. Cohen MM. Bannayan-Riley-Ruvalcaba syndrome: renaming three formerly recognized syndromes as one etiologic entity. Am J Med Genet 1990;35:291.
2. Starink TM, Van der Arwert JPW, De Waal LP, De Lange GG, Gille JJP, Eriksson AW. The Cowden syndrome: a clinical and genetic study in 21 patients. Clin Genet 1986;29:222-33.
3. Eng C. Cowden syndrome. J Genet Counsel 1997;6:181-91.
4. Fargnoli MC, Orlow SJ, Semel-Concepcion J, Bolognia JL. Clinicopathologic findings in the Bannayan-Riley-Ruvalcaba syndrome. Arch Dermatol 1996;132:1214-18.
5. Liaw D, Marsh DJ, Li J, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat Genet 1997;16:64-7.
6. Nelen MR, van Staveren WC, Peeters EA, et al. Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease. Hum Mol Genet 1997;6:1383-7.
7. Marsh DJ, Dahia PLM, Zheng Z, et al. Germline mutations in PTEN are present in Bannayan-Zonana syndrome. Nat Genet 1997;16:333-4.
8. Li J, Yen C, Liaw D, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997;275:1943-6.
9. Ittman M. Allelic loss on chromosome 10 in prostate adenocarcinoma. Cancer Res 1996;56:2143-7.
10. Marsh DJ, Zheng Z, Zedenius J, et al. Differential loss of heterozygosity in the region of the Cowden locus within 10q22-q23 in follicular thyroid adenoma and carcinomas. Cancer Res 1997;57:500-3.
11. Steck PA, Pershouse MA, Jasser SA, et al. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997;15:356-62.
12. Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by TGFβ. Cancer Res 1997;57:2124-5.
13. Kong D, Suzuki A, Zou TT, et al. PTEN1 is frequently mutated in primary endometrial carcinomas. Nat Genet 1997;17:143-4.
14. Marsh DJ, Coulon V, Lunetta KL, et al. Mutation spectrum and genotype-phenorype analyses in Cowden disease and Bannayan-Zonana syndrome, 2 hamartoma syndromes with germline PTEN mutation. Hum Mol Genet (in press).
15. Arch EM, Goodman BK, Van Wesep RA, et al. Deletion of PTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease. Am J Med Genet 1997;71:489-93.